Covington & Burling advised Insmed Incorporated on the transaction. Insmed Incorporated (Nasdaq: INSM) (“Insmed”) announced its entrance into an agreement to amend its $350 million term...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here